ALIGNMT AI
Founded 2023 Β· 12 employees on LinkedIn Β· 2 known investors
ALIGNMT AI provides AI governance infrastructure, including governance frameworks, risk monitoring, and certification support for enterprises in regulated industries. It helps organizations deploy AI that meets safety, transparency, and compliance standards.
Also known as ALIGNMT Β· ALIGNMT.AI
Investors Β· 2
Company profile
researched Aug 2026ALIGNMT AI operates an AI governance and risk-management platform aimed at enterprises, with a primary focus on healthcare. The platform automates compliance workflows for AI systems, continuously monitors deployed models for emerging risks, and generates audit-ready documentation and transparency reporting for regulators, boards and customers. The company positions its monitoring as operating without exposing sensitive patient data, and states that it maps controls to requirements including the Coalition for Health AI (CHAI) transparency standards, ONC HTI-1, U.S. Department of Justice guidance, the EU AI Act, and ISO and NIST frameworks.
The product is organized into three modules: ALIGN Governance, for enterprise-wide policies and programmatic controls over AI usage; ALIGN Assessment, for certifying fairness and validity of AI systems across protected attributes during validation, testing and production; and ALIGN Mitigation, an off-the-shelf risk mitigation service spanning the AI lifecycle that includes bias auditing and AI red teaming as a service. Adjacent capabilities include benchmarking and governing an organization's portfolio of AI vendors, AI "report cards" for external transparency, open feedback centers for stakeholders, and advisory services. The company says it maintains de-identified real-world data assets used to benchmark customer healthcare AI products, and tracks more than 30 risk factors.
ALIGNMT AI also publishes practitioner content such as white papers on AI governance training programs and AI vendor procurement checklists, and a compliance guide covering ONC, DOJ and Joint Commission requirements. A case study on its work with a comprehensive cancer center is featured on its site, and the company states that Harvard Business School is preparing a case study on its approach to AI assurance for winter 2025.
Founding story
The company is led by CEO Andreea Bodnari, described as an MIT-trained scientist with a PhD in machine learning, a serial entrepreneur, and a former product executive at Google β where she built and scaled a B2B healthcare AI product division β and at UnitedHealth Group. She has served over a decade as a reviewer for JAMIA and is a member of the Coalition for Health AI and the NIST AI Safety Consortium.
Business model
ALIGNMT AI sells a B2B software platform, complemented by services such as bias auditing, AI red teaming as a service and expert advisory support. Prospective customers are directed to request a demo rather than self-serve sign-up.
Enterprise platform offering with associated risk-mitigation and advisory services; specific pricing is not disclosed.
Traction
The company reports working with major health systems, payers and health IT companies including EMR platforms and AI developers, and cites a case study with a comprehensive cancer center. It states that healthcare providers using the platform cut compliance preparation time by half, and that Harvard Business School is preparing a case study on its AI assurance work for winter 2025.
Latest developments
In late August 2025 the company announced a $6.5 million seed round led by AIX Ventures with participation from Sancus Ventures, Alumni Ventures and Dent Capital, to be used to expand the engineering team, accelerate product development and scale healthcare partnerships.
βΈFull profile β market position, technology, go-to-market, geography
Market position
Positioned as an AI compliance and assurance infrastructure provider for healthcare, describing itself as certified by the Coalition for Healthcare AI and citing adoption by major health systems, payers and health IT vendors. Press coverage of its seed round described the company as emerging from stealth in August 2025.
The company emphasizes healthcare-specific regulatory depth across the US and EU, continuous real-world monitoring of deployed AI systems, de-identified real-world data assets for benchmarking customer AI products, monitoring that does not expose sensitive patient data, and claimed reductions of about 50% in compliance preparation time.
Technology
A governance-first software platform that applies programmatic policy controls to AI workflows, continuously monitors production AI systems for behavioral risks such as bias and errors, tracks 30+ risk factors, runs fairness and validity assessments across protected attributes, performs risk analysis and mitigation including red teaming, and automates audit trails and transparency reporting.
Go-to-market
Direct enterprise sales driven by demo requests on the company's website, supported by thought-leadership content (white papers, compliance guides, case studies) and partnerships with healthcare organizations. The company is listed as a vendor by the Association for Community Affiliated Plans under AI automation, analytics and fraud/waste/abuse categories.
Healthcare enterprises, including health systems and hospitals, payers, and health IT companies such as electronic medical record platforms and AI developers. The platform is pitched to chief product officers, chief medical officers and chief legal officers, alongside compliance and clinical teams.
Geography
Headquartered in New York, NY (1178 Broadway Street); one press report described the company as Boston-based. The company states its platform is available in 57 countries and that it addresses both US and EU compliance regimes, with partner expansion planned across the United States and beyond.
Compiled by commissioned research from 8 cited public sources β announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed β not independently audited.
Competitors Β· 2
by search overlap
Companies competing with ALIGNMT AI for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline Β· 4
launches, deals, and filingsALIGNMT AI announced $6.5 million in seed funding led by AIX Ventures, with participation from Sancus Ventures, Alumni Ventures and Dent Capital, to expand its engineering team, accelerate product development and scale healthcare partnerships.
$6.5M source β
Press coverage of the seed round described ALIGNMT AI as emerging from stealth with $6.5M in funding to address healthcare AI compliance and risk monitoring.
The company states that Harvard Business School is preparing a case study on its approach to AI assurance, scheduled for winter 2025.
In its press release, the company states it is certified by the Coalition for Healthcare AI.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
βΈResearch sources Β· 8
primary sources listed
- ALIGNMT AIalignmt.ai Β· web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does ALIGNMT AI do?
- ALIGNMT AI sells an enterprise AI governance platform that automates compliance, risk monitoring and audit trails for healthcare AI.
- Who are ALIGNMT AI's investors?
- ALIGNMT AI's investors include AIX Ventures, Sancus Ventures.